Royalty Pharma (RPRX) Insider Trading & Ownership $30.75 -0.20 (-0.65%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Royalty Pharma (NASDAQ:RPRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.90%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$16.76 MNumber OfInsiders Selling(Last 3 Years)9Amount OfInsider Selling(Last 3 Years)$203.91 M Get RPRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Royalty Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RPRX Insider Buying and Selling by Quarter Royalty Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/4/2024Rory B RiggsDirectorSell35,702$27.55$983,590.10 1/2/2024Rory B RiggsDirectorSell235,200$28.52$6,707,904.00 12/27/2023Avara Management LtdMajor ShareholderSell41,729$28.01$1,168,829.29 8/9/2023Terrance P CoyneCFOSell37,500$30.72$1,152,000.00 7/12/2023Terrance P CoyneCFOSell37,500$31.07$1,165,125.00 6/28/2023Pablo G LegorretaCEOBuy130,000$29.51$3,836,300.00 6/12/2023Pablo G LegorretaCEOBuy45,000$33.00$1,485,000.00 6/5/2023George W LloydEVPSell19,215$33.54$644,471.10 6/2/2023George W LloydEVPSell93,907$33.64$3,159,031.48 5/24/2023Pablo G LegorretaCEOBuy150,000$32.25$4,837,500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/22/2023Rory B RiggsDirectorSell1,750,000$32.82$57,435,000.00 5/16/2023Pablo G LegorretaCEOBuy160,388$33.57$5,384,225.16 3/29/2023Rory B RiggsDirectorSell9,926$36.95$366,765.70 3/28/2023George W LloydEVPSell100,000$37.06$3,706,000.00 2/22/2023Marshall UristEVPSell23,333$37.30$870,320.90 12/12/2022Rory B RiggsDirectorSell40,010$41.98$1,679,619.80 12/9/2022Rory B RiggsDirectorSell19,990$42.07$840,979.30 12/5/2022Mario Germano GiulianiDirectorSell84,302$43.15$3,637,631.30 12/1/2022Mario Germano GiulianiDirectorSell165,000$44.10$7,276,500.00 11/21/2022George W LloydEVPSell23,631$43.11$1,018,732.41 11/17/2022Rory B RiggsDirectorSell120,000$42.33$5,079,600.00 11/10/2022George W LloydEVPSell50,000$43.85$2,192,500.00 11/8/2022Terrance P CoyneCFOSell24,500$43.47$1,065,015.00 11/2/2022Terrance P CoyneCFOSell5,500$43.06$236,830.00 9/28/2022James F ReddochEVPSell100,000$41.23$4,123,000.00 9/28/2022Mario Germano GiulianiDirectorSell32,593$41.05$1,337,942.65 9/21/2022Mario Germano GiulianiDirectorSell125,697$41.25$5,185,001.25 9/20/20221978 Sicaf Sif S.A. - Gg St GgMajor ShareholderSell267,815$41.02$10,985,771.30 9/19/2022Mario Germano GiulianiDirectorSell232,185$41.50$9,635,677.50 9/16/2022Mario Germano GiulianiDirectorSell154,986$41.72$6,466,015.92 9/14/20221978 Sicaf Sif S.A. GgMajor ShareholderSell190,860$42.48$8,107,732.80 9/14/2022Rory B RiggsDirectorSell47,975$42.41$2,034,619.75 9/7/20221978 Sicaf Sif S.A. - Gg St GgMajor ShareholderSell250,000$42.53$10,632,500.00 9/7/2022Mario Germano GiulianiDirectorSell261,881$42.66$11,171,843.46 8/25/20221978 Sicaf Sif S.A. - Gg St GgMajor ShareholderSell1,994$44.00$87,736.00 8/25/2022Mario Germano GiulianiDirectorSell500$44.00$22,000.00 8/9/2022George W LloydEVPSell11,859$43.92$520,847.28 8/9/2022Rory B RiggsDirectorSell45,000$43.73$1,967,850.00 8/1/2022Terrance P CoyneCFOSell30,000$43.19$1,295,700.00 7/27/2022George W LloydEVPSell25,100$43.76$1,098,376.00 A deadly mistake in my prediction… (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you.7/25/2022George W LloydEVPSell30,671$42.93$1,316,706.03 6/29/2022Rory B RiggsDirectorSell30,000$42.17$1,265,100.00 6/24/2022Marshall UristEVPSell23,333$43.19$1,007,752.27 6/8/2022James F ReddochEVPSell100,000$41.56$4,156,000.00 5/27/2022James F ReddochEVPSell75,000$41.08$3,081,000.00 5/23/2022George W LloydEVPSell100,000$40.27$4,027,000.00 5/19/2022James F ReddochEVPSell75,000$40.44$3,033,000.00 5/19/2022Rory B RiggsDirectorSell26,304$40.09$1,054,527.36 5/16/2022Marshall UristEVPSell23,333$39.85$929,820.05 3/29/2022Rory B RiggsDirectorSell60,000$38.59$2,315,400.00 3/21/2022Rory B RiggsDirectorSell39,867$39.05$1,556,806.35 3/18/2022Rory B RiggsDirectorSell129,222$39.55$5,110,730.10 2/24/2022Henry A FernandezDirectorBuy32,500$37.49$1,218,425.00 (Data available from 1/1/2013 forward) RPRX Insider Trading Activity - Frequently Asked Questions Who is on Royalty Pharma's Insider Roster? The list of insiders at Royalty Pharma includes 1978 Sicaf Sif S.A. - Gg St Gg, 1978 Sicaf Sif S.A. Gg, Avara Management Ltd, George W Lloyd, Henry A Fernandez, James F Reddoch, Mario Germano Giuliani, Marshall Urist, Pablo G Legorreta, Rory B Riggs, and Terrance P Coyne. Learn more on insiders at RPRX. What percentage of Royalty Pharma stock is owned by insiders? 18.90% of Royalty Pharma stock is owned by insiders. Learn more on RPRX's insider holdings. Which Royalty Pharma insiders have been buying company stock? The following insider purchased RPRX shares in the last 24 months: Pablo G Legorreta ($15,543,025.16). How much insider buying is happening at Royalty Pharma? Insiders have purchased a total of 485,388 RPRX shares in the last 24 months for a total of $15,543,025.16 bought. Which Royalty Pharma insiders have been selling company stock? The following insiders have sold RPRX shares in the last 24 months: Avara Management Ltd ($1,168,829.29), George W Lloyd ($7,509,502.58), Marshall Urist ($870,320.90), Rory B Riggs ($65,493,259.80), and Terrance P Coyne ($2,317,125.00). How much insider selling is happening at Royalty Pharma? Insiders have sold a total of 2,384,012 Royalty Pharma shares in the last 24 months for a total of $77,359,037.57 sold. Royalty Pharma Key ExecutivesMr. Pablo Gerardo Legorreta (Age 60)Founder & Chief Executive Officer and Chairman Mr. Terrance P. CoyneExecutive VP & CFOMr. George Wingate Lloyd (Age 64)Executive VP of Investments & Chief Legal Officer Compensation: $4.56MMr. Christopher Hite (Age 56)Vice Chairman & Executive VP Compensation: $4.56MDr. Marshall Jonathan Urist M.D. (Age 48)Ph.D., Executive Vice President of Research & Investments Compensation: $4.56MMr. Arthur Richard McGivern J.D.Executive Vice President of Investments & General CounselMr. Ashwin Pai M.D.Executive Vice President of InvestmentsMs. Kristin Stafford (Age 42)Senior VP & Chief Accounting Officer Mr. Eric Cornelius SchneiderSenior VP & Chief Technology OfficerDr. James Folmar Reddoch Ph.D. (Age 54)Executive VP of Investments & Chief Scientific Officer Compensation: $3.4M More Insider Trading Tools from MarketBeat Related Companies Jazz Pharmaceuticals Insider Buying Corcept Therapeutics Insider Buying Perrigo Insider Buying Supernus Pharmaceuticals Insider Buying Pacira BioSciences Insider Buying Omeros Insider Buying Nektar Therapeutics Insider Buying Assembly Biosciences Insider Buying Cumberland Pharmaceuticals Insider Buying Eli Lilly and Company Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:RPRX) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
